Description
Patent Issues in the Development of Biosimilar Medicines 2011 deals with Opportunities in EU and in developing markets , Development of Moncolonal antibodies regulation, Insulin analogues and pegylation and IP of biosimilars in advanced markets .
The event brings together Executives from R&D, Operations, Market Intelligence, Business Analysis, API Outsourcing, Business Development, Commercial, Product Planning, Project and Portfolio Management, Business Development, Intellectual Property, Regulatory Affairs, Generics, Biopharmaceuticals, Biologics, Product Management and Patents.
